Apellis Pharmaceuticals prices $150 million IPO

Apellis Pharmaceuticals Inc. has priced its $150 million initial public offering. The Louisville area's newest publicly traded company will offer 10.7 million shares at a public offering price of $14 per share, for total gross proceeds of $150 million, according to a news release. Crestwood-based Apellis also has granted the underwriters a 30-day option to by as many as 1.6 mi llion additional shares at the public offering price to cover over-allotments. The shares are expected to begin trading…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news